Created at	Source	Raw Value	Validated value
June 25, 2022, 9 p.m.	usa	Percentage of Participants with Adverse Events (AEs);Percentage of Participants with Adverse Events of Special Interest (AESIs);Percentage of Participants with Change in SARS-CoV-2 pseudovirus neutralizing titers;Percentage of Participants with Incidence of medically attended AEs (MAAEs);Percentage of Participants with Serious Adverse Events (SAEs);Percentage of Participants with Solicited Local and Systemic Adverse Events (AEs)	Percentage of Participants with Adverse Events (AEs);Percentage of Participants with Adverse Events of Special Interest (AESIs);Percentage of Participants with Change in SARS-CoV-2 pseudovirus neutralizing titers;Percentage of Participants with Incidence of medically attended AEs (MAAEs);Percentage of Participants with Serious Adverse Events (SAEs);Percentage of Participants with Solicited Local and Systemic Adverse Events (AEs)